Office
900 Broadway St, Houston, TX 77012
(713) 928-2744
Family medicine in Houston, TX
No reviews yet. Be the first to review
900 Broadway St, Houston, TX 77012
(713) 928-2744
In 2025, drug and medical-device companies reported $246 in general payments to Marise Kelly (13 payments). Largest: Amgen Inc. ($55.71); Abbott Laboratories ($41.82); AstraZeneca Pharmaceuticals LP ($36.95). Reported under the federal Open Payments program.
2024 Medicare-billed services:
Billed services and units in Original Medicare Part B, 2024.
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 36415 | 28 | 24 | Insertion of needle into vein for collection of blood sample | Non-facility |
| 82962 | 26 | 15 | Blood glucose (sugar) test performed by hand-held instrument | Non-facility |
| 96160 | 12 | 12 | Administration and interpretation of patient-focused health risk assessment | Non-facility |
| 96372 | 26 | 18 | Injection of drug or substance under skin or into muscle | Non-facility |
| 99213 | 32 | 25 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Non-facility |
| 99214 | 44 | 24 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Non-facility |
| G0439 | 11 | 11 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Non-facility |
Drug units follow each billing code’s definition.
Scroll the table sideways to see every column.
| HCPCS | Drug billing units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| J0696 | 30 | 12 | Injection, ceftriaxone sodium, per 250 mg | Non-facility |
The office is at 900 Broadway St, Houston, TX 77012.
The office phone is (713) 928-2744.
Specialty: Family medicine.
Yes. Marise Kelly billed Original Medicare Part B services in 2024 (see Medicare activity above).
Marise Kelly's NPI is 1124056304.
All reviews are moderated. Review policy